KLOW blend
Four compounds in one vial. Each has its own thin evidence base, and the combination has none at all.
Not approved anywhere
| What it is | A blend of GHK-Cu, KPV, BPC-157 and TB-500. KPV is a three-amino-acid fragment of alpha-MSH with anti-inflammatory activity in animal models of colitis. |
|---|---|
| How it is thought to work | Each component is covered on its own page. The blend's rationale is that tissue repair, inflammation and skin are addressed together. |
| What the evidence actually shows | There are no studies of this combination. None. Whatever is known comes from each ingredient separately, and combining compounds can change how each behaves — that interaction has not been studied here. |
| Regulatory status | Not approved. No component of this blend is an approved injectable drug in the US. |
| Dosing | No established human dose, for the blend or for any component in it. |
| In the catalog as |
Risks and cautions
- Blends make it impossible to tell which component caused a reaction.
- Fixed ratios mean you cannot adjust one component without changing all of them.
- Contains copper — see the GHK-Cu entry.
Before you act on any of this
This page describes what is known and what is not. It is not a recommendation to use anything, and it is not a protocol. Compounds listed as research chemicals are not approved medicines and are not sold for human use. Talk to a doctor who knows your history.